References
1. Saleh M., Kamath B.M., Chitayat D. Alagille syndrome: clinical perspectives. Appl Clin Genet. 2016; 9: 75.
2. Kamath B.M., Podkameni G., Hutchinson A.L., Leonard L.D., Gerfen J., Krantz I.D., et al. Renal anomalies in Alagille syndrome: a disease-defining feature. Am J Med Genet A. 2012; 158A: 85–9.
3. Kamath B.M., Piccoli D.A. Alagille syndrome. In: Diseases of the Liver in Children; New York: Springer, 2014; 2: 227–46.
4. Yuan S.-M. Pulmonary artery pathologies in Alagille syndrome: a meta-analysis. Adv Interv Cardiol. 2022; 18: 68–70.
5. Ayoub M.D., Kamath B.M. Alagille syndrome: diagnostic challenges and advances in management. Diagnostics (Basel). 2020; 10: 907.
6. Chiang C.-M., Jeng Y.-M., Ho M.-C., Lai M.-W., Li H.-Y., Chen P.-L., et al. Different clinical and genetic features of Alagille patients with progressive disease versus a jaundice-free course. JGH Open. 2022; 6 (12): 839–45.
7. Vandriel S.M., Li L.-T., She H., Wang J.-S., Gilbert M.A., Jankowska I., et al.; The Global Alagille Alliance (GALA) Study Group Natural history of liver disease in a large international cohort of children with Alagille syndrome: results from the GALA study. Hepatology. 2023; 77: 512–29.
8. Fabris L., Cadamuro M., Guido M., et al. Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling. Am J Pathol. 2007; 171 (2): 641–53.
9. Youngstrom D., Dishowitz M., Bales C., Carr E., Mutyaba P., Kozloff K., et al. Jagged1 expression by osteoblast-lineage cells regulates trabecular bone mass and periosteal expansion in mice. Bone. 2016; 91: 64–74.
10. Degtyareva A.V., Isaeva M.H., Filippova E.A., Sugak A.B., Razumovsky A. Yu. Clinical manifestations of biliary atresia in newborns: the need for an early diagnostic screening program. Voprosy detskoy dietologii [Problems of Pediatric Nutrition]. 2021; 19 (5): 46–54. (in Russian)
11. Hankeova S., Van Hul N., Laznovsky J. Sex differences and risk factors for bleeding in Alagille syndrome. EMBO Mol Med. 2022; 14 (12): e15809.
12. Li D., Mao K., Sun J., Liu J., Zhang C. Clinical and laboratory characteristics in children with Alagille syndrome: experience of a single center. Int J Gen Med. 2023; 16: 77–83.
13. Kawahara S., Imagawa K., Takeuchi S., Iwasaki T. Differential diagnosis of neonatal cholestasis by genetic testing: a case report. J Pediatr Surg Case Rep. 2023; 94: 102658.
14. Götze T., Blessing H., Grillhösl C., Gerner P., Hoerning A. Neonatal cholestasis – differential diagnoses, current diagnostic procedures, and treatment. Front Pediatr. 2015; 3: 43.
15. Menon J., Shanmugam N. Multidisciplinary management of Alagille syndrome. J Multidiscip Healthc. 2022; 15: 353–64.
16. Filippova E.A., Pykov M.I., Rychkova V.E., Degtyareva A.V., Puchkova A.A. Ultrasound in Alagille syndrome diagnosis. Ul’trazvukovaya i funktsional’naya diagnostika [Ultrasound and Functional Diagnostics]. 2017; (5): 40–53. (in Russian)
17. Romero R. The renal sequelae of Alagille syndrome as a product of altered notch signaling during kidney development. In: B. Kamath, K. Loomes (eds). Alagille Syndrome. Cham: Springer, 2018: 103–20.
18. Vandriel S., Wang J.-S., Li L., Piccoli D.A., Loomes K.M., Sokal E., et al. Clinical features and outcomes in an international cohort of 731 Alagille syndrome patients from 19 countries. Hepatology. 2019; 70: 55A–6A. DOI: https://doi.org/10.1002/hep.30940
19. Gilbert M.A., Bauer R.C., Rajagopalan R., et al. Alagille syndrome mutation update: Comprehensive overview of JAG1 and NOTCH2 mutation frequencies and insight into missense variant classification. Hum Mutat. 2019; 40: 2197–220.
20. Nicastro E., D’Antiga L. Next generation sequencing in pediatric hepatology and liver transplantation. Liver Transpl. 2018; 24 (2): 282–93.